2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Articles

171 - 

Projet Rebuild the Evidence Base Rebuild the Evidence Base (REB) project: a method of interpreting randomised clinical trials and their meta-analysis to present patients with robust benefit-risk assessments

Hélène Vaillant-Roussel, Clara Blanchard, Thibault Menini, Elodie Charuel, Bruno Pereira et al.

Projet Rebuild the Evidence Base. Exercer, 2023, 34 (190), pp.81-88.

DOI : https://doi.org/10.56746/EXERCER.2023.190.81

 

172 - 

Consensus Statement on the definition and classification of metabolic hyperferritinaemia

Luca Valenti, Elena Corradini, Leon Adams, Elmar Aigner, Saleh Alqahtani et al.

Nature Reviews Endocrinology, 2023, 19 (5), pp.299-310.

DOI : https://doi.org/10.1038/s41574-023-00807-6

Pubmed : 36805052

 

173 - 

Dyadic coping strategies and quality of care experience: An original study of patients living with multiple sclerosis and their caregivers

D Veillard, K. Baumstarck, S Hamonic, A Ousmen, Z Hamidou et al.

Revue Neurologique, 2023, 179 (10), pp.1118-1127.

DOI : https://doi.org/10.1016/j.neurol.2023.02.072

Pubmed : 37718212

 

174 - 

Débitmétrie : outil de suivi chez les patients avec vessie neurologique traités par neurostimulation tibiale postérieure ? Uroflowmetry: A follow-up tool for neurogenic bladder patients treated by transcutaneous tibial posterior stimulation?

Lisa Viallard, Caroline Voiry, Stéphanie Mazé, Sylvie Fontaine, Jacques Kerdraon et al.

Débitmétrie : outil de suivi chez les patients avec vessie neurologique traités par neurostimulation tibiale postérieure ?. Progrès en Urologie, 2023, 33 (8-9), pp.421-426.

DOI : https://doi.org/10.1016/j.purol.2023.02.001

Pubmed : 36922295

 

175 - 

Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial

Veronique Vitton, François Mion, Anne‐marie Leroi, Charlène Brochard, Benoit Coffin et al.

United European Gastroenterology Journal, 2023, 11 (4), pp.337-349.

DOI : https://doi.org/10.1002/ueg2.12373

Pubmed : 37186357

 

176 - 

Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

Sandra Vukusic, Clarisse Carra-Dalliere, Jonathan Ciron, Elisabeth Maillart, Laure Michel et al.

Multiple Sclerosis Journal, 2023, 29 (1), pp.11-36.

DOI : https://doi.org/10.1177/13524585221129472

Pubmed : 36317497

 

177 - 

Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society

Sandra Vukusic, Romain Marignier, Jonathan Ciron, Bertrand Bourre, Mikael Cohen et al.

Multiple Sclerosis Journal, 2023, 29 (1), pp.37-51.

DOI : https://doi.org/10.1177/13524585221130934

Pubmed : 36345839

 

178 - 

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study

Sarah Wilson, Floriane Calocer, Fabien Rollot, Mathieu Fauvernier, Laurent Remontet et al.

The Lancet Regional Health - Europe, 2023, 24, pp.100542.

DOI : https://doi.org/10.1016/j.lanepe.2022.100542

Pubmed : 36426377

 

179 - 

Identification of Parkinson's Disease Subtypes from Resting-State Electroencephalography

Sahar Yassine, Ute Gschwandtner, Manon Auffret, Joan Duprez, Marc Vérin et al.

Movement Disorders, 2023, 38 (8), pp.1451-1460.

DOI : https://doi.org/10.1002/mds.29451

Pubmed : 37310340

 

180 - 

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study

Fabien Zagnoli, Amelie Leblanc, Irina Viakhireva-Dovganyuk, Jean-Philippe Delabrousse-Mayoux, Alain Pouyet et al.

Journal of Neural Transmission, 2023, 130 (11), pp.1463-1474.

DOI : https://doi.org/10.1007/s00702-023-02609-6

Pubmed : 36862190